Caris Life Sciences Inc (CAI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 09-2015 | 06-2015 | 03-2015 | 12-2014 | |
| Sales | 65,692 | 66,117 | 59,366 | 58,492 | 58,810 |
| Cost of Goods | 5,354 | 4,818 | N/A | N/A | N/A |
| Gross Profit | 60,338 | 61,299 | 59,366 | 58,492 | 58,810 |
| Operating Expenses | 63,292 | 38,861 | 36,232 | 34,842 | 31,208 |
| Operating Income | -2,600 | 23,256 | 23,134 | 23,650 | 27,602 |
| Interest Expense | 9,479 | 8,967 | 9,047 | 8,778 | 8,649 |
| Other Income | -121 | -2 | -100 | 41 | -779 |
| Pre-tax Income | -12,200 | 14,287 | 13,987 | 14,913 | 18,174 |
| Income Tax | 581 | 1,272 | 1,057 | 1,342 | 2,334 |
| Net Income Continuous | -12,781 | 13,015 | 12,930 | 13,571 | 15,840 |
| Minority Interests | 38 | 26 | 41 | 29 | 65 |
| Net Income | $-12,819 | $12,989 | $12,889 | $13,542 | $15,775 |
| EPS Basic Total Ops | -0.60 | 0.62 | 0.61 | 0.65 | 0.86 |
| EPS Basic Continuous Ops | -0.60 | 0.62 | 0.61 | 0.65 | 0.85 |
| EPS Diluted Total Ops | -0.59 | 0.62 | 0.60 | 0.64 | 0.83 |
| EPS Diluted Continuous Ops | -0.59 | 0.62 | 0.60 | 0.64 | 0.83 |
| EBITDA(a) | $46,210 | $46,691 | $45,961 | $45,756 | $49,487 |